Could cannabis reduce opioid use in gynecology and obstetrics?
A growing body of evidence suggests cannabis may reduce opioid use for gynecological pain conditions, but its use during pregnancy carries potential risks that lack strong causal evidence.
Quick Facts
What This Study Found
Reports suggest cannabis use is associated with decreased opioid consumption in conditions including ovarian, uterine, endometrial, and cervical cancers, as well as chronic pelvic pain. However, cannabis use during pregnancy has been associated with adverse maternal and neonatal outcomes, though the lack of randomized controlled trials makes it difficult to establish direct causation.
Key Numbers
Review covers opioid-sparing effects across gynecologic malignancies (ovarian, uterine, endometrial, cervical cancers) and chronic pelvic pain.
How They Did This
Narrative review synthesizing available literature on cannabis as a potential opioid substitute in gynecological disorders and examining evidence on cannabis use during pregnancy.
Why This Research Matters
Opioid use in gynecology carries significant addiction risk. If cannabis can safely reduce opioid dependence for pain management, it could offer an alternative, but pregnancy considerations add complexity.
The Bigger Picture
The tension between cannabis's potential opioid-sparing benefits in gynecology and its uncertain risks during pregnancy reflects a broader challenge in women's health research.
What This Study Doesn't Tell Us
No randomized controlled trials on cannabis as opioid substitute in gynecology. Association between cannabis and adverse pregnancy outcomes may be confounded by other factors. Review methodology is narrative, not systematic.
Questions This Raises
- ?Can cannabis safely be used for gynecological pain in non-pregnant women?
- ?What is the risk-benefit calculation for cannabis versus opioids in chronic pelvic pain?
Trust & Context
- Key Stat:
- Opioid-sparing effects reported across multiple gynecological cancers
- Evidence Grade:
- Narrative review of mostly observational evidence. No controlled trials on the opioid-substitution question in this population.
- Study Age:
- Published in 2022.
- Original Title:
- Making a joint decision: Cannabis as a potential substitute for opioids in obstetrics and gynecology.
- Published In:
- Best practice & research. Clinical obstetrics & gynaecology, 85(Pt B), 59-67 (2022)
- Database ID:
- RTHC-03825
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Can cannabis replace opioids for gynecological pain?
Some reports show decreased opioid use after cannabis initiation for conditions like chronic pelvic pain and gynecological cancers, but no randomized controlled trials have confirmed this as a safe and effective substitution strategy.
Is cannabis safe during pregnancy?
Studies have found associations between cannabis use and adverse pregnancy outcomes, but the review notes that without randomized controlled trials, a directly causal relationship has not been established.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03825APA
Eichorn, Nicole L; Shult, Hannah T; Kracht, Kelsie D; Berlau, Daniel J. (2022). Making a joint decision: Cannabis as a potential substitute for opioids in obstetrics and gynecology.. Best practice & research. Clinical obstetrics & gynaecology, 85(Pt B), 59-67. https://doi.org/10.1016/j.bpobgyn.2022.07.002
MLA
Eichorn, Nicole L, et al. "Making a joint decision: Cannabis as a potential substitute for opioids in obstetrics and gynecology.." Best practice & research. Clinical obstetrics & gynaecology, 2022. https://doi.org/10.1016/j.bpobgyn.2022.07.002
RethinkTHC
RethinkTHC Research Database. "Making a joint decision: Cannabis as a potential substitute ..." RTHC-03825. Retrieved from https://rethinkthc.com/research/eichorn-2022-making-a-joint-decision
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.